Raffles Medical Group Ltd
RAFLF
$0.8073
$0.05737.64%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.39% | -16.30% | -30.72% | -46.68% | -56.92% |
| Total Depreciation and Amortization | 18.17% | 16.90% | 17.11% | 9.96% | 2.63% |
| Total Amortization of Deferred Charges | 11.18% | -18.79% | -47.68% | -23.76% | 0.21% |
| Total Other Non-Cash Items | 112.61% | 110.02% | 107.90% | -514.54% | -192.14% |
| Change in Net Operating Assets | -117.98% | -122.84% | -123.90% | -102.26% | 216.39% |
| Cash from Operations | 13.42% | -31.76% | -54.22% | -51.14% | -48.10% |
| Capital Expenditure | 53.29% | 31.01% | 5.78% | 2.22% | -1.08% |
| Sale of Property, Plant, and Equipment | -99.87% | -49.06% | 109.49% | 308.19% | 1,048.50% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.98% | 1.47% | 9.95% | 20.30% | 33.91% |
| Cash from Investing | 74.43% | 48.61% | 20.22% | 19.52% | 18.90% |
| Total Debt Issued | -86.75% | -62.96% | -39.00% | -25.83% | -14.68% |
| Total Debt Repaid | 65.74% | 45.02% | 24.04% | 36.46% | 43.41% |
| Issuance of Common Stock | -69.25% | -91.84% | -96.24% | -88.70% | -81.56% |
| Repurchase of Common Stock | -32.03% | 33.99% | -- | 12.14% | -624.02% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.63% | 21.82% | 37.44% | 37.44% | 37.44% |
| Other Financing Activities | 32.72% | 6.29% | -28.92% | -23.80% | -19.21% |
| Cash from Financing | -28.42% | -5.30% | 11.08% | 40.22% | 56.33% |
| Foreign Exchange rate Adjustments | -278.73% | -322.31% | 206.06% | 159.72% | 139.16% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.73% | -81.27% | -98.27% | -82.38% | 25.74% |